Expertise in
19
conditions

Dr. Barbara O'brien

Neurology
Office
1515 Holcombe Blvd Unit 431, 
Houston, TX 
Offers Telehealth
Expertise in
19
conditions
Office
1515 Holcombe Blvd Unit 431, 
Houston, TX 

Overview

Barbara O'brien is a Neurologist practicing medicine in Houston, Texas.

Dr. O'brien is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

She is actively involved in clinical research, co-authoring 59 peer reviewed articles and participating in 7 clinical trials.

Specialties

Neurology

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Magnolia Health
  • HMO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Office
1515 Holcombe Blvd Unit 431, Houston, TX 77030
Other Locations
UT MD Anderson Cancer Center
210 Ashville Ave # 408, Cary, NC 27518

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
Enrollment Status: Active_not_recruiting
Publish Date: June 17, 2026
Intervention Type: Other, Drug
Study Drugs: Temozolomide, Veliparib
Study Phase: Phase 2/Phase 3
Genomically-Guided Treatment Trial in Brain Metastases
Genomically-Guided Treatment Trial in Brain Metastases
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Paxalisib, Entrectinib
Study Phase: Phase 2
Phase 2 Study of VAL-083 Treatment for MGMT Unmethylated Bevacizumab-naïve Glioblastoma in the Adjuvant or Recurrent Setting
Phase 2 Study of VAL-083 Treatment for MGMT Unmethylated Bevacizumab-naïve Glioblastoma in the Adjuvant or Recurrent Setting
Enrollment Status: Completed
Publish Date: August 29, 2025
Intervention Type: Drug
Study Drugs: VAL-083, Dianhydrogalactitol
Study Phase: Phase 2
A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors
A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors
Enrollment Status: Withdrawn
Publish Date: April 17, 2024
Intervention Type: Drug
Study Drugs: Tepotinib, Tepotinib+Osimertinib
Study Phase: Phase 1
Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Drug, Other
Study Phase: Phase 2
Phase II Study of Laser Interstitial Thermal Therapy (LITT) in Recurrent Glioblastoma
Phase II Study of Laser Interstitial Thermal Therapy (LITT) in Recurrent Glioblastoma
Enrollment Status: Terminated
Publish Date: August 10, 2022
Intervention Type: Procedure, Drug
Study Phase: Phase 2
A Phase 2, Multicenter Study of Tesevatinib in Subjects With Non-Small Cell Lung Cancer, EGFR Activating Mutation, Prior Treatment With a Tyrosine Kinase Inhibitor, and Brain Metastases or Leptomeningeal Metastases
A Phase 2, Multicenter Study of Tesevatinib in Subjects With Non-Small Cell Lung Cancer, EGFR Activating Mutation, Prior Treatment With a Tyrosine Kinase Inhibitor, and Brain Metastases or Leptomeningeal Metastases
Enrollment Status: Completed
Publish Date: March 16, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

59 Total Publications

Breaking Barriers in Leptomeningeal Disease: A SNO-ASCO Consensus Review on Clinical Trial Design and Basic Science Integration.
Breaking Barriers in Leptomeningeal Disease: A SNO-ASCO Consensus Review on Clinical Trial Design and Basic Science Integration.
Journal: Neuro-oncology
Published: January 22, 2026
Similar Doctors
Expertise in
30
conditions
Expertise in
30
conditions
Referral may be required

Houston Methodist Department Of Neurology-Texas Medical Center

6560 Fannin St Ste 802, 
Houston, TX 
 (0.3 miles away)
713-441-3780
Languages Spoken:
English
See accepted insurances

Tetsuo Ashizawa is a Neurologist practicing medicine in Houston, Texas. Dr. Ashizawa is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, Spinocerebellar Ataxia Type 10, Drug Induced Dyskinesia, and Deep Brain Stimulation.

Expertise in
21
conditions
Expertise in
21
conditions
Referral may be required

UT MD Anderson Cancer Center

1515 Holcombe Blvd, 
Houston, TX 
 (0.6 miles away)
713-792-2121
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Vinay Puduvalli is a Neurologist practicing medicine in Houston, Texas. Dr. Puduvalli is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Glioblastoma, and Gliomatosis Cerebri.

Expertise in
15
conditions
Expertise in
15
conditions
Referral may be required

Houston Methodist Stanley H. Appel Department Of Neurology

6560 Fannin St Ste 802, 
Houston, TX 
 (0.3 miles away)
713-441-3780
Languages Spoken:
English
See accepted insurances
Offers Telehealth

William Ondo is a Neurologist practicing medicine in Houston, Texas. Dr. Ondo is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Restless Legs Syndrome, Essential Tremor, Movement Disorders, Thalamotomy, and Deep Brain Stimulation.

Frequently Asked Questions about Dr. Barbara O'brien

How do I make an appointment with Dr. Barbara O'brien?

You can book an appointment with Dr. Barbara O'brien by calling their office at 713-792-6600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Barbara O'brien a top-rated expert for Glioblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Barbara O'brien is classified as an Elite expert for Glioblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Barbara O'brien specialize in?

While Dr. Barbara O'brien is a Neurology, they have specific expertise in Glioblastoma, Astrocytoma, and Glioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Barbara O'brien participate in research or clinical trials?

Yes. Dr. Barbara O'brien has published 59 articles and abstracts on conditions like Glioblastoma. You can view a list of Dr. Barbara O'brien's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Barbara O'brien accept my insurance?

Dr. Barbara O'brien accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 713-792-6600 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. O'brien's expertise for a condition
ConditionClose
View All 11 Distinguished Conditions
View All 17 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile